Related references
Note: Only part of the references are listed.Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness
John A. Stapleton et al.
ADDICTION (2008)
Varenicline for Tobacco Dependence
J. Taylor Hays et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
H-J Aubin et al.
THORAX (2008)
Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist -: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up
Mitchell Nides et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of maintenance therapy with varenicline on smoking cessation - A randomized controlled trial
Serena Tonstad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute
Sidney C. Smith et al.
CIRCULATION (2006)
Varenicline:: An α4β2 nicotinic receptor partial agonist for smoking cessation
JW Coe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease
P Quist-Paulsen et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review
JA Critchley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cigarette smoking and cardiovascular disease: Pathophysiology and implications for treatment
NL Benowitz
PROGRESS IN CARDIOVASCULAR DISEASES (2003)
Molecular biology and electrophysiology of neuronal nicotinic receptors of rat chromaffin cells
S Di Angelantonio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study
S Tonstad et al.
EUROPEAN HEART JOURNAL (2003)